Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease
Open accessThe DOI matches its Crossref record; 82 of the 84 references it cites were found in a registry or an index.
Abstract
Diabetic kidney disease (DKD) remains the leading cause of end-stage renal disease (ESRD) and is therefore a major burden on the healthcare system. Patients with DKD are highly susceptible to developing cardiovascular disease, which contributes to increased morbidity and mortality rates. While progress has been made to inhibit the acceleration of DKD, current standards of care reduce but do not eliminate the risk of DKD. There is growing appreciation for the role of inflammation in modulating the process of DKD. The focus of this review is on providing an overview of the current status of knowledge regarding the pathologic roles of inflammation in the development of DKD. Finally, we summarize recent therapeutic advances to prevent DKD, with a focus on the anti-inflammatory effects of newly developed agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189 · cited 1×
“Importantly, this trial showed no imbalance in rates of amputation or bone fracture, and no new safety concerns were identified [53].”
BackgroundEmpagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Wanner, C., Inzucchi, S. E., Lachin, J. M., Fitchett, D., von Eynatten, M., Mattheus, M., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Zinman, B. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515920 · Cited by 3,655 · cited 1×
“For example, the renal composite outcomes (doubling of creatinine, renal replacement therapy, or renal death) decreased by 46% in patients with type 2 diabetes treated with empagliflozin [52].”
BackgroundNrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
Kobayashi, E. H., Suzuki, T., Funayama, R., Nagashima, T., Hayashi, M., Sekine, H., Tanaka, N., Moriguchi, T., Motohashi, H., Nakayama, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms11624 · Cited by 1,878 · cited 1×
“reported that Nrf2 binds to the regulatory regions of inflammatory genes and thereby induces their transcription in macrophages and alleviates RNA polymerase II recruitment [37].”
BackgroundAdler, A. I., Stevens, R. J., Manley, S. E., Bilous, R. W., Cull, C. A., Holman, R. R., & UKPDS Group (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00712.x · Cited by 1,816
Rosenstock, J., Perkovic, V., Johansen, O. E., Cooper, M. E., Kahn, S. E., Marx, N., Alexander, J. H., Pencina, M., Toto, R. D., Wanner, C., et al. (2019) · JAMA · doi:10.1001/jama.2018.18269 · Cited by 1,084
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
Pergola, P. E., Raskin, P., Toto, R. D., Meyer, C. J., Huff, J. W., Grossman, E. B., Krauth, M., Ruiz, S., Audhya, P., Christ-Schmidt, H., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105351 · Cited by 890 · cited 1×
“Bardoxolone methyl, one such Nrf2 activator, has been demonstrated in clinical trials to have reno-protective effects in patients with type 2 diabetes [40].”
BackgroundTranscriptome Analysis of Human Diabetic Kidney Disease
Woroniecka, K. I., Park, A. S. D., Mohtat, D., Thomas, D. B., Pullman, J. M., & Susztak, K. (2011) · Diabetes · doi:10.2337/db10-1181 · Cited by 642
Pathogenesis and Treatment of Chronic Kidney Disease: A Review of Our Recent Basic and Clinical Data
Tomino, Y. (2014) · Kidney and Blood Pressure Research · doi:10.1159/000368458 · Cited by 566
Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
Zheng, H., Whitman, S. A., Wu, W., Wondrak, G. T., Wong, P. K., Fang, D., & Zhang, D. D. (2011) · Diabetes · doi:10.2337/db11-0807 · Cited by 507
Xu, L., Nagata, N., Nagashimada, M., Zhuge, F., Ni, Y., Chen, G., Mayoux, E., Kaneko, S., & Ota, T. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.05.028 · Cited by 493
Cited by
Items 101–200 of 230
Impact of inflammatory markers on the relationship between sleep quality and diabetic kidney disease
Meng, L., Yi, D., Li, J., Li, X., Yan, T., Yang, M. H., Song, H., Lv, S., Wang, N., Li, Y., et al. (2021) · Sleep And Breathing · doi:10.1007/s11325-021-02380-6 · Cited by 15
Iridoids modulate inflammation in diabetic kidney disease: A review
Zhou, T., Tian, N., Li, L., & Yu, R. (2024) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2024.03.010 · Cited by 15
Vukelić, I., Šuša, B., Majanović, S. K., Buljević, S., Pršo, A.-M. L., Belančić, A., Rahelić, D., & Detel, D. (2024) · Diabetology · doi:10.3390/diabetology5070052 · Cited by 13
Liu, X., Zhai, X., Wang, X., Zhu, X., Wang, Z., Jiang, Z., Bao, H., & Chen, Z.-H. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2024.0653 · Cited by 13
Diabetic proximal tubulopathy: Can we mimic the disease for in vitro screening of SGLT inhibitors?
Faria, J., Gerritsen, K. G. F., Nguyen, T. Q., Mihaila, S. M., & Masereeuw, R. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174378 · Cited by 14
Sultan, S., Alharbi, M., Alrayes, N. M., Makki, N., Faruqui, H. M., Basuni, L., Alhozali, A. M., Abdulnoor, R., Borai, A., Almalki, A., et al. (2023) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.449 · Cited by 14
Aging and Diabetic Kidney Disease: Emerging Pathogenetic Mechanisms and Clinical Implications
Chen, Y., Kanwar, Y. S., Chen, X., & Zhan, M. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230621112215 · Cited by 12
Yuan, Y., Liu, Y., Sun, M., Ye, H., Feng, Y., Liu, Z., Pan, L., & Weng, H. (2022) · Open Life Sciences · doi:10.1515/biol-2022-0506 · Cited by 12
Wang, L., Su, J., Liu, Z., Ding, S., Li, Y., Hou, B., Hu, Y., Dong, Z., Tang, J., Liu, H., et al. (2024) · BioData Mining · doi:10.1186/s13040-024-00369-x · Cited by 14
Zhang, X., Deng, H., Tong, J. D., Wang, Y. Z., Ning, X. C., Yang, X. H., Zhou, F., & Jin, H. M. (2020) · Journal of Diabetes Research · doi:10.1155/2020/2817972 · Cited by 12
Wu, C., Zhang, R., Wang, J., Chen, Y., Zhu, W., Yi, X., Wang, Y., Wang, L., Liu, P., & Li, P. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115508 · Cited by 13
Neutrophil-to-lymphocyte ratio associated with renal function in type 2 diabetic patients
Gao, J., Shen, J., Yang, L., Liu, L., Zhao, K., Pan, X., Li, L., & Xu, J.-J. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i14.2308 · Cited by 11
Role of the Nox4/AMPK/mTOR signaling axe in adipose inflammation-induced kidney injury
Njeim, R., Farhat, T., Alkhansa, S., Youssef, N., Dia, B., Slika, R., Diab, R. H., Azar, S. T., & Eid, A. A. (2020) · Clinical Science · doi:10.1042/cs20190584 · Cited by 12
Koch, B., Fuhrmann, D. C., Schubert, R., Geiger, H., Speer, T., & Baer, P. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031811 · Cited by 11
ALMOUSA, L. A., AlFaris, N. A., Alshammari, G. M., Alsayadi, M. M. S., ALTAMIMI, J. Z., Alagal, R. I., & Yahya, M. A. (2022) · Science Progress · doi:10.1177/00368504221102751 · Cited by 11
Cox, E. J., Alicic, R. Z., Neumiller, J. J., & Tuttle, K. R. (2020) · US Endocrinology · doi:10.17925/use.2020.16.2.80 · Cited by 10
Liao, Y., Hu, H., Wan, Q., & Song, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1598197 · Cited by 10
Potential Medicinal Value of Rhein for Diabetic Kidney Disease
Mao, X., Xu, D., Yue, S., Fu, R., Zhang, S., & Tang, Y. (2023) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-022-3591-y · Cited by 10
Coptisine mitigates diabetic nephropathy via repressing the NRLP3 inflammasome
Zhai, J., Li, Z., Zhang, H., Lu, Z., Zhang, Y., Li, M., Kang, J., Yang, Z., Ma, L., Ma, L., et al. (2023) · Open Life Sciences · doi:10.1515/biol-2022-0568 · Cited by 9
Varra, F., Theodosis‐Nobelos, P., Varra, V., & Varras, M. N. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47121063 · Cited by 8
Chen, S., & Liang, Y. (2022) · Life · doi:10.3390/life12030380 · Cited by 8
Saliu, T. P., Yazawa, N., Hashimoto, K., Miyata, K., Kudo, A., Horii, M., Kamesawa, M., Kumrungsee, T., & Yanaka, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020899 · Cited by 8
Swaminathan, S. M., Rao, I. R., Bhojaraja, M. V., Attur, R. P., Nagri, S. K., Rangaswamy, D., Shenoy, S. V., & Nagaraju, S. P. (2024) · Journal of the National Medical Association · doi:10.1016/j.jnma.2023.12.001 · Cited by 7
Fu, Z.-Y., Wan, M., Jin, T., Lai, S., Li, X., Sun, X., & Gao, W. (2024) · Cellular and Molecular Biology · doi:10.14715/cmb/2024.70.5.15 · Cited by 7
Sardar, A., Abid, O., Rehman, W. U., Rasheed, L., Alanazi, M. M., Daud, S., Rafiq, M., Wadood, A., & Shakeel, M. (2024) · Royal Society Open Science · doi:10.1098/rsos.240543 · Cited by 7
FSTL1 aggravates high glucose-induced oxidative stress and transdifferentiation in HK-2 cells
Zhang, B., Geng, H., Zhao, K. X., Omorou, M., Liu, S., Ye, Z., Zhang, F., Luan, H., & Zhang, X. (2025) · Scientific Reports · doi:10.1038/s41598-024-84462-5 · Cited by 8
Júnior, P. A. B. M., Lass, A. D., de Bortolo, J. L., Anizelli, L. B., Rocha, M. T., Proença, H., Carvalhal, S. R. S., Mehanna, S. H., Nagashima, S., Fernandes, L. C., et al. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00552 · Cited by 8
GLP-1 Receptor Agonists in the Treatment of Patients with Type 2 Diabetes and Chronic Kidney Disease
Neumiller, J. J., Alicic, R. Z., & Tuttle, K. R. (2022) · Kidney and Dialysis · doi:10.3390/kidneydial2030034 · Cited by 7
Zhuang, L., Jin, G., Wang, Q., Ge, X., & Pei, X. (2023) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-023-04721-5 · Cited by 7
The Correlation between Microalbuminuria and Thyroid Nodules in Type 2 Diabetic Mellitus
Cao, C., Cui, Z.-L., Miao, J., Zhou, J., Wang, X., & Jin, J. (2022) · International Journal of Endocrinology · doi:10.1155/2022/2789279 · Cited by 7
Functional role of histamine receptors in the renal cortical collecting duct cells
Sudarikova, A. V., Fomin, M. V., Sultanova, R. F., Zhao, Y., Perez, S. L., Domondon, M., Shamatova, M. M., Lysikova, D. V., Spires, D. R., & Ilatovskaya, D. V. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00420.2021 · Cited by 7
Li, H.-L., Dong, L., Wei, H.-L., Li, H., Tian, M., & Dong, J.-W. (2025) · European journal of medical research · doi:10.1186/s40001-025-02671-8 · Cited by 6
Safety of ChAdOx1 nCoV-19 vaccination in patients with end-stage renal disease on hemodialysis
Yang, I.-N., Lu, C.-L., Tang, H.-J., Kuo, Y.-C., Tsai, L.-H., Tu, K.-C., Wang, J.-J., & Chien, C.-C. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273676 · Cited by 7
Fukuda, T., Fujii, A., Akihisa, T., Otsubo, N., Murakami, M., Yamada, T., & Maki, C. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12124089 · Cited by 6
A novel composite polydopamine-based hydrogel dressing that heals diabetic ulcers
Shi, S., Yang, M. J., Jiang, T., Liu, Y., Yang, J., Kalvakolanu, D. V., Tang, J., Zhang, L., Ren, H. J., & Guo, B. (2025) · Materials & Design · doi:10.1016/j.matdes.2025.114810 · Cited by 5
Li, Y., Wang, M., Wu, X., Chen, J., Peng, X., Gan, Y., Huang, X., Wang, J., & Yang, C. (2026) · The FASEB Journal · doi:10.1096/fj.202502662r · Cited by 6
Current Landscape and Emerging Therapeutic Targets in Diabetic Kidney Disease
Hu, S., Lee, K., He, C., & Fan, Y. (2026) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000001053 · Cited by 5
Spennati, G., Vo, N., Regier, M. C., Ward, H. H., Das, V., Karihaloo, A., & Freedman, B. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2026.103081 · Cited by 5
Wang, J., Ni, R., Jiang, T., Peng, D., Ming, Y., Cui, H., & Liu, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1222642 · Cited by 5
Yang, C., Huang, F., Fang, H., & Zang, Y. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s456205 · Cited by 6
Relation of the intense physical exercise and asprosin concentrations in type 2 diabetic rats
Katar, M., & Gevrek, F. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102501 · Cited by 6
Li, W., Xu, G., & Li, M. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1494162 · Cited by 5
L-ergothioneine; a potential adjuvant in the management of diabetic nephropathy
Dare, A., Channa, M. L., & Nadar, A. (2021) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2021.100033 · Cited by 5
Inibidores de SGLT2 e inflamassoma NLRP3: alvo potencial na doença renal do diabetes
Júnior, P. A. B. M., Lass, A. D., Pilger, B. I., Fornazari, R., de Moraes, T. P., & Pinho, R. A. (2024) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2023-0187pt · Cited by 6
Effect of SDF-1 and CXCR4 gene variants on the development of diabetic kidney disease
Ting, K.-H., Yang, P., Su, S., Tsai, P.-Y., & Yang, S. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.103186 · Cited by 5
Zhang, X., Fang, Y., Weng, M., Chen, C., Xu, Y., & Wan, J. (2024) · PeerJ · doi:10.7717/peerj.18493 · Cited by 4
Cobb, M. B., Wu, W., Attipoe, E. M., Johnson, A. C., & Garrett, M. R. (2021) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00487.2020 · Cited by 4
Pokrzywnicka, P., Kwiendacz, H., Nabrdalik, K., Hajzler, W., Adamczyk, P., Moczulski, D. K., Trautsolt, W., Grzeszczak†, W., & Gumprecht, J. (2022) · Endokrynologia Polska · doi:10.5603/ep.a2022.0001 · Cited by 4
Ли, Б., Ye, S., Fan, Y., Lin, Y., Li, S., Peng, H., Diao, H., & Chen, W. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.934555 · Cited by 4
Wan, L., Qian, Y., Ni, W., Lu, Y., Li, W., Pan, Y., & Chen, W. (2023) · PubMed Central · doi:10.12122/j.issn.1673-4254.2023.12.09 · Cited by 7
Yang, A., Ye, H., Liu, X., Li, Y., Liu, H., Ye, S., Hu, Y., Zhuang, P., Zhang, Y., Zheng, C., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15880 · Cited by 3
Jiang, F., Huang, X., Yan, M., Tan, J., Dong, X., Liu, X., He, J., Ali, A. M. M., Chen, M., Zhang, L., et al. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/5291562 · Cited by 3
Ma, J., Yang, J., Wang, W., Quan, Y., Liao, X.-N., Bai, Y.-H., & Jiang, H. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s514319 · Cited by 3
Ni, Y., Du, H., Wu, X., Pan, Y., Yang, W., Zheng, L., Zheng, Y., Jin, H., Fu, Z., Cai, C., et al. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.110061 · Cited by 4
Lifestyles, metabolome and diabetic kidney disease: a cohort study
Deng, B., Zheng, Y., Zhou, Z., Xu, L., Li, F., & Zhang, C. (2025) · QJM · doi:10.1093/qjmed/hcaf281 · Cited by 3
Diabetic kidney disease, biomarkers, and finerenone
Verma, A., & Upadhyay, A. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70464 · Cited by 5
Hamdi, M., Rahimizadeh, A., Ahmadi, M., Davoodi, M., Sadegh‐Nejadi, S., Ghafourian, A., Choobineh, H., & Afrisham, R. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11523-5 · Cited by 4
Gao, S., Dong, C., Li, H., Li, J., & Abula, A. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116307 · Cited by 3
Li, N., & Zhou, H. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220617153331 · Cited by 5
Du, H., Wang, Y., Zhu, Y., Li, X., Zhu, T., Wu, Q., & Zha, F. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303267375231204103200 · Cited by 3
The Mechanism and Research Progress of miRNA-21 in Diabetic Kidney Disease
刘, 静. (2021) · Advances in Clinical Medicine · doi:10.12677/acm.2021.1112915 · Cited by 3
Inflammation in Diabetic Kidney Disease: Focus on New Therapeutic Considerations
Leehey, D. J., & Zhang, X. (2023) · Medical Research Archives · doi:10.18103/mra.v11i2.3614 · Cited by 3
Zare, S., Hasani, M., Estêvão, M. D., Tahmasebi, R., Azadbakht, L., Shidfar, F., Heshmati, J., & Ziaei, S. (2023) · Clinical Nutrition Research · doi:10.7762/cnr.2023.12.4.293 · Cited by 3
Vildagliptin Nephroprotective Effect in Rats Model with Cisplatin-Induced Nephrotoxicity
Watife, A. T., Bairam, A. F., & Al-Ghuraibawi, N. H. A. (2024) · Journal of Contemporary Medical Sciences · doi:10.22317/jcms.v10i1.1481 · Cited by 3
Martiz, R. M., Ramu, R., Nambisan, H., Suhail, A., Raish, M., Patil, S. M., Ashwini, P., Mahesh, B., Przybyłek, M., Bełdowski, P., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0331192 · Cited by 3
Diabetic nephropathy and inflammation
Lestarini, A. (2022) · Jurnal kedokteran dan kesehatan Indonesia · doi:10.20885/jkki.vol13.iss2.art1 · Cited by 3
Yang, Y., Tan, H., ZHANG, X., Huang, M., Bei, W., & Jiao, G. U. O. (2022) · Journal of Holistic Integrative Pharmacy · doi:10.1016/s2707-3688(23)00064-x · Cited by 3
Wang, L., Li, H., Guo, X., & Wang, X. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1475441 · Cited by 2
Luo, S., Lan, Y., Zhang, R., & 栾仲秋 (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1737091 · Cited by 4
Maresin 1 Ameliorates Diabetic Kidney Disease in Mice by Promoting Macrophage M2 Polarization
Pu, Y., Ma, X., Geng, K., Meng, R., Li, Y., Zheng, C., Zhao, C.-Y., Teng, F., & Xu, Y. (2026) · Mediators of Inflammation · doi:10.1155/mi/4334095 · Cited by 2
Innate immunity in diabetic nephropathy: Pathogenic mechanisms and therapeutic targets
Chen, L., Lu, S., Wu, Z., Zhang, E., Cai, Q., & Zhang, X. (2024) · MedComm – Future Medicine · doi:10.1002/mef2.76 · Cited by 2
Deng, J., & Wu, P. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40151 · Cited by 2
Shen, X., Liu, Y., Zhao, J., Cheng, Q., & Yang, G. (2025) · Scientific Reports · doi:10.1038/s41598-025-05701-x · Cited by 2
Urinary Interleukins and Kidney Damage in Diabetes
Moresco, R. N., Bochi, G. V., Cardoso, M. B. S., & de Carvalho, J. A. M. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81303-1_12-1 · Cited by 2
Yu, L., & Tao, H. (2022) · Biochemical Genetics · doi:10.1007/s10528-022-10250-3 · Cited by 1
Xie, J., Zheng, B., Sihai, W., Guoming, S., & Zhaohui, F. (2023) · PubMed Central · doi:10.19852/j.cnki.jtcm.20230124.001 · Cited by 1
Kallem, C. J., Alghwiri, A. A., Yabes, J. G., Roumelioti, M., Erickson, S. J., Rollman, B. L., Weisbord, S. D., Unruh, M. L., Yoram Vodovotz, B., Jhamb, M., et al. (2024) · Kidney360 · doi:10.34067/kid.0000000000000512 · Cited by 1
THE ROLE OF OXIDATIVE STRESS IN CHRONIC KIDNEY DISEASE (CKD)
Aboolian, A., Younes, J., Romero, A., Jha, J. C., Jandeleit-Dahm, K. A. M., & Meister, A. J. (2025) · Wiley eBooks · doi:10.1002/9781119790419.ch17 · Cited by 2
Li, T., Li, L., Sun, Z., Zeng, H., Guo-yong, H., Tian, Z., Chen, D., & Li, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-11097-5 · Cited by 1
Fu, C., Deng, Z., Gan, S., Zhou, H., & Zhou, Q. (2025) · European journal of medical research · doi:10.1186/s40001-025-03240-9 · Cited by 1
Swaminathan, S. M., Nagaraju, S. P., Bhojaraja, M. V., Rao, I. R., Attur, R. P., Rangaswamy, D., Shenoy, S. V., Gupta, A., Ballala, K., & Laxminarayana, S. L. K. (2025) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2026.270714 · Cited by 1
Yang, H., Chen, J., Zhu, P., Yuan, M., Mao, S., He, Y., Wang, X., Wang, J., Wang, X., & Wang, X. (2026) · Frontiers in Chemistry · doi:10.3389/fchem.2026.1739085 · Cited by 1
Is There a Role for Pentoxifylline in Diabetic Kidney Disease? A Mini Review
Leehey, D. J., & Agarwal, R. (2026) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2025.09.030 · Cited by 1
Wang, Y., Huang, G., Zhao, B., Zhu-qing, Y., Xu, M., Chang, Y.-Z., Wu, L.-J., Bao, X.-C., Yang, J., Liu, Z., et al. (2026) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x26500473 · Cited by 1
de Oliveira, B. M., Araújo, L. S., da Silva, C. A., Rocha, L. P., da Silva, R. B., dos Reis, M. A., Trevisan, R. O., Zaidan, B. C., & Machado, J. R. (2026) · Mediators of Inflammation · doi:10.1155/mi/9937801 · Cited by 1
Vasilkova, V., Mokhort, T., Bayrasheva, V. K., Коротаева, Л. Е., Yarets, Y. I., Shestovets, O., Borovets, Y., & Науменко, Е. П. (2020) · Juvenis scientia · doi:10.32415/jscientia_2020_6_2_35-43 · Cited by 1
Histopathological evaluation of kidney disease in patients with diabetes mellitus
Shrestha, J. R., Dahal, K., Baral, A., & Hada, R. (2021) · Journal of Patan Academy of Health Sciences · doi:10.3126/jpahs.v8i2.37751 · Cited by 1
Li, Z., Liang, D., Xiao, Y., Dai, Y., Fujun, A., Ding, J., Shi, M., Xiao, Y., & Guo, B. (2021) · PubMed · doi:10.12122/j.issn.1673-4254.2021.10.10 · Cited by 1
Urinary Interleukins and Kidney Damage in Diabetes
Moresco, R. N., Bochi, G. V., Cardoso, M. B. S., & de Carvalho, J. A. M. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_12 · Cited by 1
Interleukin-6 gene polymorphism (rs1800796) in patient with diabetic nephropathy among Balinese
Wati, G. A. P. R., Lestarini, A., Aryastuti, S. A., Permatananda, P. A. N. K., & Cahyawati, P. N. (2023) · Jurnal kedokteran dan kesehatan Indonesia · doi:10.20885/jkki.vol14.iss3.art9 · Cited by 1
da Costa, C. C. P., Assunção, L. D. P., Santos, K. D. F., Silva, L. D., Santos, R. D. S., & Reis, Â. A. D. S. (2024) · Journal of Molecular Pathology · doi:10.3390/jmp5030024 · Cited by 1
Das, S., & Ramanathan, G. (2024) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30661 · Cited by 1
Dimu, P. S., Icksan, A. G., Farhat, F., Jonny, J., Hernowo, B. A., & Putranto, T. A. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46120822 · Cited by 1
Fan, J., Kong, C., Yu, B., Wang, R., & Qi, Z. (2025) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073364424241202111833 · Cited by 1
BIOMARKERS OF OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES
Sultana, R., Cenini, G., & Butterfield, D. A. (2025) · Wiley eBooks · doi:10.1002/9781119790419.ch18 · Cited by 1
Li, W., Luo, Y., Liu, R., Zhao, M., Yang, Y., Zhao, J., Zhao, C., & Hong, B. (2025) · Journal of Chromatography B · doi:10.1016/j.jchromb.2025.124610 · Cited by 1
DsbA-L protects against diabetic renal injury through the adipo-renal axisPreprint
Zeng, L., Yang, M., Hu, C., Zhao, L., Chen, X., Wei, Y., & Lin, H. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.12.426410 · Cited by 1
Yang, Z., Wu, M., Chen, N., Zhou, H., Yuan, C., Zhou, Z., Mu, L., Dong, J., Bian, Y., & Shi, Y. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4061018 · Cited by 1
Rai, A., Senthilkumar, G. P., & Mehalingam, V. (2021) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-021-01018-3
[Diabetes and oral contraceptives].
Aragón, J. A. V., & González, E. L. D. L. O. (1974) · PubMed
Metadata
- Authors
- Matoba, K., Takeda, Y., Nagai, Y., Kawanami, D., Utsunomiya, K., & Nishimura, R.
- Affiliations
- Jikei University School of Medicine (JP)
- Fukuoka University (JP)
- Corresponding author
- Matoba, Keiichiro
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-07-10
- Volume
- 20
- Issue
- 14
- Pages
- 3393
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6678414
- OpenAlex
- W2958949191
- Semantic Scholar
- 1919f7691771fef371eec317a2f8802ae08a78f7
- Cited by
- 223
- References
- 84
- Citations by year
- 2026: 19 · 2025: 30 · 2024: 40 · 2023: 26 · 2022: 44 · 2021: 36 · 2020: 22 · 2019: 5
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (18K15985)
- Ichiro Kanehara Foundation (N/A)
- MSD Life Science Foundation (N/A)
- Yokoyama Foundation for Clinical Pharmacology (N/A)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- diabetic nephropathy, inflammation, pathogenesis, end-stage renal disease, cardiovascular disease, anti-inflammatory therapy, novel therapeutic agents
- MeSH terms
- Animals, Diabetic Nephropathies, Disease Susceptibility, Humans, Inflammation, Signal Transduction, Biomarkers, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.